Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 6, 2006, Pages 1274-1278

  Chenia, Hafizah Y ^a,b   Pillay, Balakrishna ^a   Pillay, Dorsamy ^a,c  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c DURBAN UNIVERSITY OF TECHNOLOGY   (South Africa)

Author keywords

Energy dependent efflux systems; Fluoroquinolone resistance; GyrA and ParC alterations; LPS; OMP

Indexed keywords

AMPICILLIN; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CIPROFLOXACIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GREPAFLOXACIN; LOMEFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OUTER MEMBRANE PROTEIN F; PIPERACILLIN; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CODON; CONTROLLED STUDY; DNA SEQUENCE; DRUG ACCUMULATION; DRUG MECHANISM; DRUG TRANSPORT; DRUG UPTAKE; ESCHERICHIA COLI; GENE AMPLIFICATION; GENE MUTATION; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; NONHUMAN; PHENOTYPE; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SPECTROPHOTOMETRY; STRAIN DIFFERENCE; URINARY TRACT INFECTION; WILD TYPE;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; CIPROFLOXACIN; CYTOPLASM; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FLUOROQUINOLONES; HUMANS; LIPOPOLYSACCHARIDES; MOLECULAR WEIGHT; MUTATION; PLASMIDS; POLYMERASE CHAIN REACTION; URINARY TRACT INFECTIONS;

EID: 33845370997     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl404     Document Type: Article

References (14)

1. Gales AC, Jones RN, Gordon KA et al. Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: Report from the second year of the SENTRY Antimicrobial Surveillance Program (1998). J Antimicrob Chemother 2000; 45: 295-303.
2. Everett MJ, Jin YF, Ricci V et al. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob Agents Chemother 1996; 40: 2380-6.
3. Ruiz J. Mechanisms of resistance to quinolones: Target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 2003, 51: 1109-17.
4. Mortimer PGS, Piddock LJV. A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother 1991; 28: 639-53.
5. Cohen SP, McMurry LM, Hooper DC et al. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: Decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob Agents Chemother 1989; 33: 1318-25.
6. Rodriguez-Martinez JM, Pascual A, Garcia I et al. Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type β-lactamase. J Antimicrob Chemother 2003; 52: 703-6.
7. National Committee for Clinical Laboratory Standards. Methods for Diffusion Disk Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard M7-A5. NCCLS, Wayne, PA, USA, 2000.
8. Sawai T, Hiruma R, Kawana N et al. Outer membrane permeation of β-lactam antibiotics in Escherichia coli, Proteus mirabilis and Enterobacter cloacae. Antimicrob Agents Chemother 1982; 22: 585-92.
9. Carlone GM, Thomas ML, Rumschlag HS et al. Rapid micro-procedure for isolating detergent-insoluble outer membrane proteins from Haemophilus species. J Clin Microbiol 1986; 24: 330-2.
10. Vila J, Ruiz J, Goni P et al. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 1995; 39: 1201-3.
11. Vila J, Ruiz J, Goni P et al. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother 1996; 40: 491-3.
12. Piddock LJV, Hall MC, Walters RN. Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply resistant (marA) type strains. J Antimicrob Chemother 1991; 28: 185-98.
13. Ma D, Cook DN, Alberti DM et al. Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J Bacteriol 1993; 175: 6299-313.
14. Randall LP, Woodward MJ. The multiple antibiotic resistance (mar) locus and its sigificance. Res Vet Sci 2002; 72: 87-93.